| Previous close | 89.67 |
| Open | 90.42 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 88.42 - 90.61 |
| 52-week range | 76.45 - 106.66 |
| Volume | |
| Avg. volume | 1,757,202 |
| Market cap | 111.109B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | 17.39 |
| EPS (TTM) | 5.10 |
| Earnings date | 03 Feb 2023 |
| Forward dividend & yield | 3.33 (3.71%) |
| Ex-dividend date | 06 May 2022 |
| 1y target est | 102.70 |
- Zacks
The Zacks Analyst Blog Highlights Expedia, IDEXX Laboratories, Tradeweb Markets, SolarEdge Technologies and Sanofi
Expedia, IDEXX Laboratories, Tradeweb Markets, SolarEdge Technologies and Sanofi are included in this Analyst Blog.
- Zacks
J&J (JNJ) Down as Court Rejects Bankruptcy Claim in Talc Lawsuits
A federal appeals court rejects J&J's (JNJ) efforts to shift over 38,000 lawsuits related to its talcum-based baby powder out of trial courts and into bankruptcy court.
- Bloomberg
Advil Maker Haleon Said to Study Potential Deals to Bulk Up
(Bloomberg) -- Haleon Plc, the consumer health business spun out from British pharmaceutical producer GSK Plc, is in the early stages of studying large potential deals to bulk up its brand portfolio, people with knowledge of the matter said. Most Read from BloombergSony Slashes PlayStation VR2 Headset Output After Pre-Orders DisappointPutin’s War in Ukraine Pushes Ex-Soviet States Toward New AlliesBrexit Is Costing the UK £100 Billion a Year in Lost OutputTrump Sues Journalist Bob Woodward for R
